Abstract:The deacetylase sirtuin 1 (Sirt1), activated by calorie restriction and fasting, exerts several complementary effects on cellular function that are favourable to healthspan; it is often thought of as an 'anti-aging' enzyme. Practical measures which might boost Sirt1 activity are therefore of considerable interest. A number of nutraceuticals have potential in this regard. Nutraceuticals reported to enhance Sirt1 synthesis or protein expression include ferulic acid, tetrahydrocurcumin, urolithin A, melatonin, astaxanthin, carnosic acid and neochlorogenic acid. The half-life of Sirt1 protein can be enhanced with the natural nicotinamide catabolite N1-methylnicotinamide. The availability of Sirt1's obligate substrate NAD+ can be increased in several ways: nicotinamide riboside and nicotinamide mononucleotide can function as substrates for NAD+ synthesis; activators of AMP-activated kinase-such as berberine-can increase expression of nicotinamide phosphoribosyltransferase, which is rate limiting for NAD+ synthesis; and nutraceutical quinones such as thymoquinone and pyrroloquinoline quinone can boost NAD+ by promoting oxidation of NADH. Induced ketosis-as via ingestion of medium-chain triglycerides-can increase NAD+ in the brain by lessening the reduction of NAD+ mediated by glycolysis. Post-translational modifications of Sirt1 by O-GlcNAcylation or sulfonation can increase its activity, suggesting that administration of glucosamine or of agents promoting hydrogen sulfide synthesis may aid Sirt1 activity. Although resveratrol has poor pharmacokinetics, it can bind to Sirt1 and activate it allosterically-as can so-called sirtuin-activating compound drugs. Since oxidative stress can reduce Sirt1 activity in multiple ways, effective antioxidant supplementation that blunts such stress may also help preserve Sirt1 activity in some circumstances. Combination nutraceutical regimens providing physiologically meaningful doses of several of these agents, capable of activating Sirt1 in complementary ways, may have considerable potential for health promotion. Such measures may also amplify the benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors in non-diabetic disorders, as these benefits appear to reflect upregulation of Sirt1 and AMP-activated protein kinase activities.

Resveratrol Serves As a Protein-Substrate Interaction Stabilizer in Human SIRT1 Activation

Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol

Systematic Insight of Resveratrol Activated SIRT1 Interactome through Proximity Labeling Strategy

Resveratrol-Induced Sirt1 Activation Derives from Sirt1 Phosphorylation by LKB1

SIRT1, resveratrol and aging

Resveratrol-induced Sirt1 phosphorylation by LKB1 mediates mitochondrial metabolism

Small Molecules as SIRT Modulators

Resveratrol Regulates Hsp60 in HEK 293T Cells During Activation of SIRT1 Revealed by Nascent Protein Labeling Strategy

Sirtuin 1 as a potential molecular target of resveratrol in selected diseases

A Novel Mechanism for SIRT1 Activators That Does Not Rely on the Chemical Moiety Immediately C-Terminal to the Acetyl-Lysine of the Substrate

Therapeutic potential of resveratrol: the in vivo evidence

A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide.

Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators

Nutraceutical activation of Sirt1: a review

SIRT1 Activation by Natural Phytochemicals: An Overview

SIRT1 in metabolic syndrome: where to target matters.

Interaction between resveratrol and SIRT1: role in neurodegenerative diseases

Deciphering the Allosteric Activation Mechanism of SIRT6 Using Molecular Dynamics Simulations

Effect of Resveratrol Dimers and Tetramers Isolated from Vitaceous and Dipterocarpaceous Plants on Human SIRT1 Enzyme Activity

A review on SIRT3 and its natural small molecule activators as a potential Preventive and therapeutic target

Nicotinamide Riboside Activates SIRT5 Deacetylation